Corporate / M&A

Healthcare / Life Sciences

Tolremo-web-640x140

Homburger News

Share-Image Teamplate Deals-and-Cases

On September 20, 2023, TOLREMO therapeutics AG announced that it has completed its Series A financing, bringing the total amount raised to USD 39 m (CHF 34.1 m). BioMedPartners AG led the round with participation from a new investor, Pierre Fabre Invest, as well as existing investors.
TOLREMO&#8217;s mission is to stop non-genetic cancer drug resistance as it emerges by dismantling cancer&#8217;s earliest defenses to targeted therapies, thus surmounting a universal challenge for current and future targeted treatments.
The Homburger team was led by Dieter Gericke and Margrit Marti and comprised Francesco Bernasconi, Stefan Luginbühl, Thierry Burckhardt and Claudine Schär (all Corporate / M&amp;A; Healthcare / Life Sciences) as well as Stefan Oesterhelt (Tax).

Homburger advised TOLREMO therapeutics AG on the extension of its Series A financing round

Regulatory

Financial Market Regulation

Employment and Executive Compensation

GAM-web-640x140

On June 29, 2023, GAM Holding AG announced the sale of its third party fund services («FMS Businesses») in Luxembourg and Switzerland to Carne Group («the Transactions»).
The purchase price is EUR 2.25 m for the Luxembourg business and CHF 0.5 m for the Swiss business, subject to adjustments based on revenue performance at closing.
The transactions are expected to close in the fourth quarter of 2023. The announcement of the sale is a material step towards fulfilling a condition of the exchange offer by Liontrust Asset Management PLC («Liontrust») for all publicly held shares of GAM, on which Homburger also advised.
Homburger AG advised on all aspects of Swiss law relating to the Swiss part of the deal. The Homburger team was led by Claude Lambert (Corporate / M&amp;A) and included Stefan Kramer (Regulatory, Financial Market Regulation and Financial Services) and Gregor Bühler (Employment), as well as Stefan Luginbühl, Isabelle Cordey (all Corporate / M&amp;A), Alexander Wherlock and Sarah Fasel (both Regulatory and Financial Market Regulation).

Homburger advised GAM on the carve-out of its third party fund management services

Qubit-web-640x140

On June 29, 2023, the sale of a majority shareholding in Flisom AG has been successfully completed. Qubit Investments Pte Ltd, an affiliate of Tata Industries Ltd, together with several other shareholders sold its stake in the ETH Zurich spin-off, a developer and manufacturer of photovoltaic thin-film solar modules, to FL1 Holding GmbH, a Germany based investment company.
Homburger AG advised Qubit Investments on all Swiss legal aspects of the transaction. The Homburger team was led by Daniel Hasler and included Stefan Blunschi, Stefan Luginbühl, Julien Di Sabato, Martin Cattaneo and Giulia Meier (all Corporate / M&amp;A).

Stefan
Luginbühl

Homburger advised TOLREMO therapeutics AG on the extension of its Series A financing round

Homburger advised GAM on the carve-out of its third party fund management services

Homburger advised Qubit Investments on the sale of its stake in Flisom AG

Join the Team

Stefan Luginbühl

Career

Languages

Bar Registration

Teams

StefanLuginbühl

Homburger advised TOLREMO therapeutics AG on the extension of its Series A financing round

Homburger advised GAM on the carve-out of its third party fund management services

Homburger advised Qubit Investments on the sale of its stake in Flisom AG

Join the Team

Stefan Luginbühl

Career

Languages

Bar Registration

Teams

Stefan
Luginbühl